HERTFORDSHIRE, England,
PITTSBURGH, and UTRECHT, Netherlands, June 23, 2016 /PRNewswire/ -- Mylan N.V.
(NASDAQ, TASE: MYL), one of the world's leading pharmaceutical
companies, today announced a €1 million donation to the
Princess Máxima Center for Pediatric Oncology, a new national
cancer center currently being built in Utrecht, the Netherlands.
The donation from Mylan will support the Princess Máxima
Center in its mission of treating and curing children with cancer
by enhancing research efforts and supporting patients and their
families while at the center for treatment.
Mylan Executive Chairman Robert J.
Coury commented, "Mylan's mission is to set new
standards in healthcare and provide access to high quality medicine
to patients around the world; however, our mission starts with the
communities in which we operate, and we have had the privilege to
serve customers and patients in the
Netherlands for more than 17 years. The mission of the
Princess Máxima Center is closely aligned with Mylan's and I would
like to commend Prof. Pieters for his vision and leadership in
raising the standard of care for cancer in the Netherlands and ensuring children with
cancer have equal access to the best care available."
Mylan CEO Heather Bresch added,
"Every two days a child dies from cancer in the Netherlands and one in four children does
not survive their fight with this disease. Through our commitment
to providing access to oncology medications to patients around the
world, we strive to do our part to help treat and cure cancer, and
we believe our partnership with The Princess Máxima Center is just
one of the ways we can go beyond medicine to deliver better health
for a better world."
Professor Pieters, member of the board of the Princess Máxima
Center commented, "We are grateful to Mylan for their generous
support of the Princess Máxima Center, which is focused on treating
children with cancer using the best possible methods, while also
preventing the development of negative side effects in young
patients, both now and over the long term. By bringing together
expertise in care and research in the Princess Máxima Center,
the Netherlands will become a
leader in the field of pediatric oncology both in Europe and globally. It is a position that
will help us fulfill our ambition: to cure every child with cancer.
I am delighted that our collaboration with Mylan will further
support the care we provide and our continued research."
Matean Niël, Mylan country manager in the Netherlands added: "I am thrilled to see
Mylan supporting a cause in the
Netherlands that puts people and patients
first. Mylan's support of the Princess Máxima Center creates a
lot of pride among our hundreds of employees based in Bunschoten,
Weesp and Zwolle. This initiative reflects our local commitment to
institutional care in the
Netherlands."
About Mylan
Mylan is a global pharmaceutical company
committed to setting new standards in healthcare. Working together
around the world to provide 7 billion people access to high quality
medicine, we innovate to satisfy unmet needs; make reliability and
service excellence a habit; do what's right, not what's easy; and
impact the future through passionate global leadership. We offer a
growing portfolio of more than 1,400 generic and branded
pharmaceuticals, including antiretroviral therapies on which nearly
50% of people being treated for HIV/AIDS in the developing world
depend. We market our products in approximately 165 countries and
territories. Our global R&D and manufacturing platform includes
more than 50 facilities, and we are one of the world's largest
producers of active pharmaceutical ingredients. Every member of our
more than 35,000-strong workforce is dedicated to creating better
health for a better world, one person at a time. Learn more at
mylan.com
About The Princess Máxima Center
The Princess Máxima
Center brings highly complex care and research in Pediatric
Oncology in the Netherlands
together. This integration of care and research is unique and will
lead to cure more children with cancer. It also aims to become the
European leading center for Pediatric Oncology.
The Princess Máxima Center will be located in a brand new building
in Utrecht. This will be opened in
2018. Learn more at www.prinsesmaximacentrum.com.
Photo - http://photos.prnewswire.com/prnh/20160623/382857
Logo - http://photos.prnewswire.com/prnh/20140423/77793
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/mylan-donates-1-million-to-the-princess-maxima-center-for-pediatric-oncology-300289375.html
SOURCE Mylan N.V.